Home » Authors » Nuala Moran

Articles by Nuala Moran

NeuTec Raising 10M To Fund Programs Targeting Infections

Jan. 9, 2002

Strakan Raises Another £15M, Gains UK Approval For Zindaclin

Jan. 9, 2002

Antisoma, Abbott Restructure Deal Regarding Cancer Drug

Jan. 9, 2002

NeuTec Raising 10M To Fund Programs Targeting Infections

Jan. 9, 2002

Antisoma, Abbott Restructure Deal Regarding Cancer Drug

Jan. 9, 2002

Strakan Raises Another £15M, Gains UK Approval For Zindaclin

Jan. 9, 2002

PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback

Jan. 9, 2002

Microscience Collaborating With Merial On Avian Vaccine Programs

June 6, 2001

CeNeS, Elan To Form New Firm For Pain Product Development

June 6, 2001

CeNeS, Elan To Form New Firm For Pain Product Development

June 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...